In addition, in mice with breast cancer (97), the number of infiltrating CD8+ T cells and the serum levels of IFN-γ were significantly increased after PD-L1 destabilization induced by OTUD1 deletion, promoting tumor immunotherapy. The gene discussed is CD8A; the disease is breast carcinoma.